Cargando…
195 The Impact of Administration of Leukotriene Receptor Antagonists, Pranlukast-EK to Infants with Bronchial Asthma
BACKGROUND: Bronchial asthma develops by the age of 3 years frequently in childhood in industrialized countries. Pranlukast hydrate, leukotriene receptor antagonists, has been shown to be clinically effective for the treatment of hypersensitivity and childhood asthma. The generic drugs for PLK were...
| Autores principales: | , , , , , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
World Allergy Organization Journal
2012
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3512954/ http://dx.doi.org/10.1097/01.WOX.0000411952.04837.57 |